Samrat Pharmachem [SAMRATPH] vs Deepak Nitrite [DEEPAKNTR] Detailed Stock Comparison

Samrat Pharmachem

BSE

Deepak Nitrite

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Samrat Pharmachem wins in 10 metrics, Deepak Nitrite wins in 8 metrics, with 0 ties. Samrat Pharmachem appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Samrat Pharmachem	Deepak Nitrite	Better
P/E Ratio (TTM)	13.81	40.63	Samrat Pharmachem
Price-to-Book Ratio	1.37	4.58	Samrat Pharmachem
Debt-to-Equity Ratio	13.81	23.36	Samrat Pharmachem
PEG Ratio	N/A	-0.91	N/A
EV/EBITDA	13.86	26.30	Samrat Pharmachem
Profit Margin (TTM)	1.72%	7.58%	Deepak Nitrite
Operating Margin (TTM)	-0.06%	7.32%	Deepak Nitrite
EBITDA Margin (TTM)	N/A	7.32%	N/A
Return on Equity	9.91%	11.85%	Deepak Nitrite
Return on Assets (TTM)	5.85%	9.03%	Deepak Nitrite
Free Cash Flow (TTM)	$-105.99M	$-5.12B	Samrat Pharmachem
Dividend Yield	0.29%	0.41%	Deepak Nitrite
1-Year Return	-30.15%	-35.71%	Samrat Pharmachem
Price-to-Sales Ratio (TTM)	0.35	3.08	Samrat Pharmachem
Enterprise Value	$1.08B	$257.13B	Deepak Nitrite
EV/Revenue Ratio	0.38	3.21	Samrat Pharmachem
Gross Profit Margin (TTM)	3.39%	21.99%	Deepak Nitrite
Revenue per Share (TTM)	$908	$587	Samrat Pharmachem
Earnings per Share (Diluted)	$23.02	$44.56	Deepak Nitrite
Beta (Stock Volatility)	-0.32	0.12	Samrat Pharmachem

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Samrat Pharmachem vs Deepak Nitrite Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Samrat Pharmachem	-0.91%	-6.16%	-12.87%	-14.81%	-11.45%	-17.63%
Deepak Nitrite	0.08%	-2.71%	-6.35%	-14.39%	-5.19%	-27.40%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Samrat Pharmachem	-30.15%	-57.38%	181.12%	931.84%	1,575.06%	1,070.42%
Deepak Nitrite	-35.71%	-7.50%	142.52%	2,897.69%	10,083.04%	10,083.04%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Samrat Pharmachem (SAMRATPH): View Full Stock Overview

Deepak Nitrite (DEEPAKNTR): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Samrat Pharmachem vs Deepak Nitrite

Metric	SAMRATPH	DEEPAKNTR
Market Information
Market Cap i	₹982.37M	₹246.94B
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	2,495	172,361
90 Day Avg. Volume i	2,791	122,700
Last Close	₹319.50	₹1,815.00
52 Week Range	₹302.05 - ₹646.00	₹1,775.00 - ₹3,093.75
% from 52W High	-50.54%	-41.33%
All-Time High	₹1,250.00 (Sep 19, 2022)	₹3,169.00 (Jul 29, 2024)
% from All-Time High	-74.44%	-42.73%
Growth Metrics
Quarterly Revenue Growth	-0.06%	-0.13%
Quarterly Earnings Growth	-0.14%	-0.45%
Financial Health
Profit Margin (TTM) i	0.02%	0.08%
Operating Margin (TTM) i	0.00%	0.07%
Return on Equity (TTM) i	0.10%	0.12%
Debt to Equity (MRQ) i	13.81	23.36
Cash & Liquidity
Book Value per Share (MRQ)	₹232.02	₹395.08
Cash per Share (MRQ)	₹1.70	₹66.90
Operating Cash Flow (TTM) i	₹1.26M	₹7.00B
Levered Free Cash Flow (TTM) i	₹71.12M	₹6.97B
Dividends
Last 12-Month Dividend Yield i	0.29%	0.41%
Last 12-Month Dividend i	₹1.00	₹7.50

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem vs Deepak Nitrite

Metric	SAMRATPH	DEEPAKNTR
Price Ratios
P/E Ratio (TTM) i	13.81	40.63
Forward P/E i	N/A	26.22
PEG Ratio i	N/A	-0.91
Price to Sales (TTM) i	0.35	3.08
Price to Book (MRQ) i	1.37	4.58
Market Capitalization
Market Capitalization i	₹982.37M	₹246.94B
Enterprise Value i	₹1.08B	₹257.13B
Enterprise Value Metrics
Enterprise to Revenue i	0.38	3.21
Enterprise to EBITDA i	13.86	26.30
Risk & Other Metrics
Beta i	-0.32	0.12
Book Value per Share (MRQ) i	₹232.02	₹395.08

Financial Statements Comparison: Samrat Pharmachem vs Deepak Nitrite

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	SAMRATPH	DEEPAKNTR
Revenue/Sales i	₹712.03M	₹18.90B
Cost of Goods Sold i	₹687.86M	₹14.74B
Gross Profit i	₹24.17M	₹4.16B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹-346,000	₹1.38B
EBITDA i	₹185,000	₹2.14B
Pre-Tax Income i	₹-3.64M	₹1.55B
Income Tax i	₹357,000	₹424.90M
Net Income (Profit) i	₹-3.99M	₹1.12B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	SAMRATPH	DEEPAKNTR
Cash & Equivalents i	₹483,000	₹1.79B
Total Current Assets i	₹1.03B	₹32.97B
Total Current Liabilities i	₹495.83M	₹9.23B
Long-Term Debt i	₹0	₹11.14B
Total Shareholders Equity i	₹718.00M	₹54.25B
Retained Earnings i	N/A	₹48.27B
Property, Plant & Equipment i	N/A	₹24.00B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	SAMRATPH	DEEPAKNTR
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	SAMRATPH	DEEPAKNTR
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	2,495	172,361
Average Daily Volume (90 Day) i	2,791	122,700
Shares Outstanding i	3.09M	136.39M
Float Shares i	1.26M	67.98M
% Held by Insiders i	0.59%	0.50%
% Held by Institutions i	0.00%	0.26%

Dividend Analysis & Yield Comparison: Samrat Pharmachem vs Deepak Nitrite

Metric	SAMRATPH	DEEPAKNTR
Last 12-Month Dividend i	₹1.00	₹7.50
Last 12-Month Dividend Yield i	0.29%	0.41%
3-Year Avg Annual Dividend i	₹1.67	₹7.50
3-Year Avg Dividend Yield i	0.17%	0.34%
3-Year Total Dividends i	₹5.00	₹22.50
Ex-Dividend Date	Sep 19, 2024	Aug 04, 2025

Samrat Pharmachem [SAMRATPH] vs Deepak Nitrite [DEEPAKNTR] Detailed Stock Comparison